Orthofix Medical Inc (OFIX) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.040x

Based on the latest financial reports, Orthofix Medical Inc (OFIX) has a cash flow conversion efficiency ratio of -0.040x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.61 Million) by net assets ($435.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OFIX equity financing ratio to measure how much of total assets are equity-financed.

Orthofix Medical Inc - Cash Flow Conversion Efficiency Trend (1992–2025)

This chart illustrates how Orthofix Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Orthofix Medical Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Orthofix Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orthofix Medical Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Duni AB
ST:DUNI
-0.029x
TangYuan Electric
SHE:300789
-0.033x
Mirrabooka Investments Ltd
AU:MIR
-0.001x
Shinsung Tngsn
KO:005390
0.167x
Kaimei Electronic Corp
TW:2375
0.007x
Hangzhou Zhongya Machinery Co Ltd
SHE:300512
0.026x
CCP Contact Probe Co Ltd
TWO:6217
-0.031x
Lotte Non-Life
KO:000400
-0.539x

Annual Cash Flow Conversion Efficiency for Orthofix Medical Inc (1992–2025)

The table below shows the annual cash flow conversion efficiency of Orthofix Medical Inc from 1992 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Orthofix Medical Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $450.04 Million $33.35 Million 0.074x +44.55%
2024-12-31 $503.12 Million $25.79 Million 0.051x +167.08%
2023-12-31 $598.73 Million $-45.75 Million -0.076x -123.10%
2022-12-31 $336.86 Million $-11.54 Million -0.034x -162.47%
2021-12-31 $336.93 Million $18.48 Million 0.055x -73.65%
2020-12-31 $356.86 Million $74.27 Million 0.208x +112.87%
2019-12-31 $327.63 Million $32.03 Million 0.098x -34.31%
2018-12-31 $335.40 Million $49.92 Million 0.149x -17.24%
2017-12-31 $296.61 Million $53.34 Million 0.180x +5.99%
2016-12-31 $263.48 Million $44.71 Million 0.170x +13.96%
2015-12-31 $290.31 Million $43.22 Million 0.149x -12.46%
2014-12-31 $299.63 Million $50.96 Million 0.170x -21.53%
2013-12-31 $311.18 Million $67.44 Million 0.217x +671.90%
2012-12-31 $399.10 Million $11.21 Million 0.028x -86.34%
2011-12-31 $315.17 Million $64.78 Million 0.206x +45.61%
2010-12-31 $300.89 Million $42.47 Million 0.141x -32.13%
2009-12-31 $240.27 Million $49.97 Million 0.208x +56.98%
2008-12-31 $202.06 Million $26.77 Million 0.132x +167.45%
2007-12-31 $433.94 Million $21.50 Million 0.050x +138.04%
2006-12-31 $392.63 Million $8.17 Million 0.021x -92.80%
2005-12-31 $368.88 Million $106.67 Million 0.289x +212.66%
2004-12-31 $297.17 Million $27.48 Million 0.092x -29.95%
2003-12-31 $240.78 Million $31.79 Million 0.132x -19.83%
2002-12-31 $177.95 Million $29.30 Million 0.165x +26.93%
2001-12-31 $145.43 Million $18.87 Million 0.130x -67.39%
2000-12-31 $141.51 Million $56.31 Million 0.398x +357.70%
1999-12-31 $97.20 Million $8.45 Million 0.087x +24.90%
1998-12-31 $86.20 Million $6.00 Million 0.070x +5.62%
1997-12-31 $69.80 Million $4.60 Million 0.066x +102.80%
1996-12-31 $67.70 Million $2.20 Million 0.032x -57.48%
1995-12-31 $61.50 Million $4.70 Million 0.076x -59.96%
1994-12-31 $46.10 Million $8.80 Million 0.191x -27.35%
1993-12-31 $37.30 Million $9.80 Million 0.263x +133.18%
1992-12-31 $28.40 Million $3.20 Million 0.113x --

About Orthofix Medical Inc

NASDAQ:OFIX USA Medical Devices
Market Cap
$476.98 Million
Market Cap Rank
#13249 Global
#3218 in USA
Share Price
$11.80
Change (1 day)
+0.08%
52-Week Range
$8.95 - $16.23
All Time High
$67.71
About

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhanc… Read more